Azenta

Azenta

AZTA

Azenta is a premier life sciences tools and services company, formed from the transformation of Brooks Automation's life sciences division. Its mission is to provide innovative solutions for sample management, genomic analysis, and biological materials storage, accelerating scientific discovery and therapeutic development. The company operates through two main segments: Life Sciences Products and Life Sciences Services, leveraging automation and informatics to serve a global client base. Its strategic direction focuses on expanding its automated cold chain storage systems and high-value genomic services.

AZTA · Stock Price

USD 21.86-13.66 (-38.46%)
Market Cap: $1.0B

Historical price data

Market Cap: $1.0BPatents: 4Employees: 2000-3000HQ: United States

AI Company Overview

Azenta is a premier life sciences tools and services company, formed from the transformation of Brooks Automation's life sciences division. Its mission is to provide innovative solutions for sample management, genomic analysis, and biological materials storage, accelerating scientific discovery and therapeutic development. The company operates through two main segments: Life Sciences Products and Life Sciences Services, leveraging automation and informatics to serve a global client base. Its strategic direction focuses on expanding its automated cold chain storage systems and high-value genomic services.

Biotech

Technology Platform

Integrated platform combining automated ultra-low temperature sample storage systems, sample management informatics software, and a full suite of genomic services (sequencing, gene synthesis) to support life sciences research and biopharma development.

Funding History

1
IPOUndisclosed

Opportunities

Azenta is poised to capitalize on the rapid growth in biologics and cell/gene therapies, which require sophisticated sample management.
The trend towards laboratory automation and outsourcing of genomic services presents significant cross-selling opportunities for its integrated platform.

Risk Factors

Key risks include dependence on biopharma R&D spending cycles, intense competition from larger tool providers, and execution risks associated with integrating acquired businesses like B Medical Systems into its operational model.

Competitive Landscape

Azenta competes with Hamilton Storage and SPT Labtech in automation, and with Eurofins and Illumina in genomic services. Its main differentiation is offering an integrated suite of hardware, software, and services for end-to-end sample management, providing a 'one-stop-shop' solution for complex research needs.